Bougard Marine

Main Referenced Co-authors

BURTEA, Carmen (5)

KAHVECIOGLU, Zehra Cagla (5)

LAURENT, Sophie (5)

SAUSSEZ, Sven (5)

Vandecasteele, Samuel (5)

Main Referenced Keywords

apoptosis (4); EGFR (4); therapeutic peptide (3); targeted therapy (2); Anaplastic thyroid carcinoma (1);

Main Referenced Unit & Research Centers

CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (5)

Main Referenced Disciplines

Oncology (4)

Anatomy (cytology, histology, embryology...) & physiology (3)

Biochemistry, biophysics & molecular biology (2)

Chemical engineering (1)

Pharmacy, pharmacology & toxicology (1)

Publications (total 5)

Search in publications

The most downloaded

41 downloads

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Sarah Peeters, Daubry, A., Laurent, S., Saussez, S., & Burtea, C. (06 February 2024). Toward the development of a novel drug using engineered peptides designed for EGFR-mediated drug delivery of an apoptosis inducer in anaplastic thyroid carcinoma [Paper presentation]. Télévie Seminar. https://hdl.handle.net/20.500.12907/48533

Kahvecioglu, Z. C., Baillif, R., Vandecasteele, S., Bougard, M., Daubry, A., Rasson, O., Martens, C., Appels, M., Laurent, S., Saussez, S., & Burtea, C. (23 May 2025). Dual Targeting of EGFR and of PAM pathway: An innovative Peptide-Based therapeutic strategy for anaplastic thyroid carcinoma [Paper presentation]. EDT-CANCEROLOGY ANNUAL MEETING, Mons, Belgium.

https://hdl.handle.net/20.500.12907/52555

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Laurent, S., Saussez, S., & Burtea, C. (22 October 2024). Novel approach in the treatment of anaplastic thyroid cancer using EGFR-and PIP3-targeted synthetic peptides to inhibit the PI3K/AKT/mTOR signaling pathway [Paper presentation]. 9th Annual Peptide Therapeutics Symposium, La Jolla, United States - California.

https://hdl.handle.net/20.500.12907/49921

https://hdl.handle.net/20.500.12907/48533

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (24 November 2023). Innovative drug delivery system using EGFR-targeted engineered peptides in anaplastic thyroid cancer treatment [Poster presentation]. PhD Day SFMBBM 2023, Liège, Belgium.

https://hdl.handle.net/20.500.12907/46851

Peer reviewed

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Rogien, C., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (27 October 2023). Novel therapeutic approaches for EGFR-mediated drug delivery using engineered peptides in anaplastic thyroid cancer [Poster presentation]. Annual BACR Meeting 2023 Friday October 27th, CIRCADIAN CYCLE, CHRONOBIOLOGY AND CANCER, brussels, Belgium.

https://hdl.handle.net/20.500.12907/46914

Peer reviewed